These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 31448584)

  • 1. Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study.
    Shi T; Song X; Liu Q; Yang Y; Yu L; Liu B; Wei J
    Cancer Med; 2019 Oct; 8(13):6010-6020. PubMed ID: 31448584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival impact of gastrectomy and chemotherapy on gastric signet ring-cell carcinoma with different metastatic lesions: A population-based study.
    Ji J; Zhang X; Yuan S; Liu H; Yang L
    Asian J Surg; 2024 Apr; 47(4):1769-1775. PubMed ID: 38302357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score-Matched Analysis of a Large Population-Based Study.
    Li Q; Zou J; Jia M; Li P; Zhang R; Han J; Huang K; Qiao Y; Xu T; Peng R; Song Q; Fu Z
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31116140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy is associated with increased survival from colorectal signet ring cell carcinoma with distant metastasis: A Surveillance, Epidemiology, and End Results database analysis.
    Shi T; Huang M; Han D; Tang X; Chen Y; Li Z; Liu C; Xiang D; Wang T; Chen Y; Wang R; Lei Z; Chu X
    Cancer Med; 2019 Apr; 8(4):1930-1940. PubMed ID: 30864303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
    Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
    [No Abstract]   [Full Text] [Related]  

  • 9. Microangiopathic Hemolytic Anemia Is a Late and Fatal Complication of Gastric Signet Ring Cell Carcinoma: A Systematic Review and Case-Control Study.
    Lam R; Tarangelo N; Wang R; Horibe M; Grimshaw AA; Jain D; Haffar S; Bazerbachi F; Kunz PL; Li DK
    Oncologist; 2022 Sep; 27(9):751-759. PubMed ID: 35589098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and outcomes in stage I-III mucinous gastric adenocarcinoma: a retrospective study at a single medical center.
    Hsu JT; Wang CW; Le PH; Wu RC; Chen TH; Chiang KC; Lin CJ; Yeh TS
    World J Surg Oncol; 2016 Apr; 14():123. PubMed ID: 27112436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
    Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
    World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
    Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
    World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population.
    Warschkow R; Baechtold M; Leung K; Schmied BM; Nussbaum DP; Gloor B; Blazer Iii DG; Worni M
    Gastric Cancer; 2018 Mar; 21(2):324-337. PubMed ID: 28646258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients.
    Lu M; Yang Z; Feng Q; Yu M; Zhang Y; Mao C; Shen L; Tang J
    Medicine (Baltimore); 2016 Jul; 95(27):e4052. PubMed ID: 27399088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative gastrectomy for metastatic gastric adenocarcinoma: A national population-based cohort study.
    Kamarajah SK; Markar SR; Phillips AW; Salti GI; Dahdaleh F; Griffiths EA
    Surgery; 2021 Dec; 170(6):1702-1710. PubMed ID: 34389165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study.
    Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J
    World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study.
    Gertsen EC; van der Veen A; Brenkman HJF; Brosens LAA; van der Post RS; Verhoeven RHA; Luijten JCHBM; Vissers PAJ; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP
    Ann Surg Oncol; 2024 Mar; 31(3):1760-1772. PubMed ID: 38127213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
    Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
    Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
    Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
    Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
    Fu J; Wu L; Jiang M; Tan Y; Li D; Chen F; Jiang T; Du J
    J Surg Oncol; 2016 Dec; 114(8):1004-1008. PubMed ID: 27891617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.